---
title: "Network-guided discovery of candidate biomarkers for COPD comorbidities using deep learning"
id: "biorxiv-19-network-guided-identification-of-candidate-biomarkers-for-copd-associated"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-19-network-guided-identification-of-candidate-biomarkers-for-copd-associated"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.10.26.761000v1?rss=1"
published_at: "2026-10-30T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Network-guided discovery of candidate biomarkers for COPD comorbidities using deep learning
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-19-network-guided-identification-of-candidate-biomarkers-for-copd-associated
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.10.26.761000v1?rss=1)
- **Published At:** 2026-10-30T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors trained a convolutional-neural-network ensemble, called the functional-distance model (FDM), on drug-target-indication relationships to score proteins within a Human Protein Network (HPN). - The HPN comprised 17,302 proteins and 492,195 relationships; it was encoded with 20 graph-derived features to represent network topology. - Resubstitution performance of the FDM on the training set produced an apparent balanced accuracy of 0.811 and Matthews correlation coefficient (MCC) of 0.627; these values were reported as not independent estimates of generalization. - A COPD-centred network search evaluated 2,645 nearby proteins and retained 224 candidates using a COPD FDM score threshold greater than 0.50. - Candidate proteins were tested in independently assembled public patient-derived transcriptomic data using simple one-feature classifiers and cross-validation; the source reports saved cross-validation predictions. - The exploratory transcriptomic panel nominated GTF2I for bacterial infection, UBXN7 for type 2 diabetes, LIFR for hypertension, SRGN for lung neoplasm and FGF4 for pneumonitis. - Cross-validation results across the saved predictions showed balanced accuracy ranging 0.838–0.970 and MCC ranging 0.726–0.941 for these classifiers, as reported. - The authors noted direct experimental support exists for **SRGN** in non-small-cell lung cancer, while other candidates have varying indirect mechanistic support and should be considered hypotheses rather than validated biomarkers. - The manuscript frames its main contribution as methodological: a reusable two-stage framework combining network-based functional prioritization with patient-derived molecular discrimination to generate comorbidity-specific biomarker hypotheses from an index disease state. - The authors explicitly state that prospective longitudinal cohorts are required before claims of progression prediction or clinical utility can be made.
## Clinical Analysis & Structured Key Points
Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data | bioRxiv Skip to main content New Results Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data View ORCID Profile Jose Manuel Mas , Esther Ramirez , View ORCID Profile Xavier Daura doi: https://doi.org/10.64898/2026.10.26.761000 Jose Manuel Mas 1 Universitat Autonoma de Barcelona; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jose Manuel Mas Esther Ramirez 2 Independent Researcher Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xavier Daura 1 Universitat Autonoma de Barcelona; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Xavier Daura For correspondence: xavier.daura{at}uab.cat Abstract Info/History Metrics Preview PDF Abstract Chronic obstructive pulmonary disease (COPD) frequently coexists with infections, metabolic disease, cardiovascular disease, inflammatory lung injury and lung cancer. Molecular markers derived by comparing a comorbidity with healthy controls need not identify the transition from an established COPD state to that comorbidity. We therefore developed a two-stage computational strategy that asks a narrower question: which proteins can distinguish COPD samples from samples annotated with a specific COPD-associated comorbidity? First, a Human Protein Network (HPN; 17,302 proteins and 492,195 relationships) was encoded by 20 graph-derived features. A convolutional-neural-network ensemble, termed the functional-distance model (FDM), was trained on known drug-target-indication relationships. Stored training-set predictions yielded an apparent balanced accuracy of 0.811 and Matthews correlation coefficient (MCC) of 0.627; these values describe resubstitution performance and are not an independent estimate of generalization. The COPD-centred network search evaluated 2,645 nearby proteins and retained 224 candidates using a COPD FDM score above 0.50. Candidate expression was then tested in independently assembled public patient-derived transcriptomic data using simple one-feature classifiers and cross-validation. The resulting exploratory panel contained GTF2I for bacterial infection, UBXN7 for type 2 diabetes, LIFR for hypertension, SRGN for lung neoplasm and FGF4 for pneumonitis. Across the saved cross-validation predictions, balanced accuracy ranged from 0.838 to 0.970 and MCC from 0.726 to 0.941. SRGN has direct experimental support in non-small-cell lung cancer, whereas the remaining candidates have varying indirect mechanistic support and should be regarded as hypotheses rather than established disease biomarkers. This work demonstrates an orthogonal discovery framework in which network-based functional prioritization and patient-derived molecular discrimination constrain one another. Its main contribution is methodological: it provides a reusable strategy for generating comorbidity-specific biomarker hypotheses from an index-disease state. Prospective longitudinal cohorts are required before claims of progression prediction or clinical utility can be made. Competing Interest Statement The authors have declared no competing interest. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted October 30, 2026. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data Jose Manuel Mas , Esther Ramirez , Xavier Daura bioRxiv 2026.10.26.761000; doi: https://doi.org/10.64898/2026.10.26.761000 Share This Article: Copy Citation Tools Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data Jose Manuel Mas , Esther Ramirez , Xavier Daura bioRxiv 2026.10.26.761000; doi: https://doi.org/10.64898/2026.10.26.761000 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Animal Behavior and Cognition (8164) Biochemistry (19027) Bioengineering (15171) Bioinformatics (45520) Biophysics (22958) Cancer Biology (20182) Cell Biology (27395) Clinical Trials (138) Developmental Biology (14186) Ecology (21452) Epidemiology (2067) Evolutionary Biology (25862) Genetics (16385) Genomics (23892) Immunology (19087) Microbiology (43339) Molecular Biology (18414) Neuroscience (95417) Paleontology (715) Pathology (3041) Pharmacology and Toxicology (5219) Physiology (8300) Plant Biology (16324) Scientific Communication and Education (2119) Synthetic Biology (4662) Systems Biology (10420) Zoology (2432)
## Related Clinical Research

- [Physical activity intensity linked to lower self-reported emphysema in older US adults (NHANES ana](https://medichelpline.com/clinical-feed/plos-one-5-association-between-physical-activity-intensity-and-self-reported-emphysema-a.md)
- [Nonlinear association of sleep quality (PSQI) with type 2 diabetes prevalence in community chronic](https://medichelpline.com/clinical-feed/plos-one-18-nonlinear-relationship-between-sleep-quality-and-prevalence-of-type-2-diabetes.md)
- [Pemafibrate as a senotherapeutic for COPD via TFEB-driven autophagy and mitophagy regulation](https://medichelpline.com/clinical-feed/medrxiv-4-senotherapeutic-role-of-pemafibrate-through-autophagy-mitophagy-regulation-in.md)
- [Perioperative Aspirin Continuation and Outcomes After MIS-ATP Lumbar Fusion](https://medichelpline.com/clinical-feed/pubmed-42773907.md) (DOI: 10.1097/BRS.0000000000005878)
- [Pheochromocytoma Mimicking Septic Shock After Tirzepatide: Severe Lactic Acidosis Case Report](https://medichelpline.com/clinical-feed/pubmed-43024315.md) (DOI: 10.1097/MD.0000000000051565)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.